Research compound · lyophilised

Tirzepatide

€45.00

Tirzepatide is a synthetic dual receptor agonist research peptide addressing the GLP-1 and GIP receptors. Dual incretin compounds are widely used in metabolic research on glucose handling and energy balance. Supplied as lyophilised powder in sealed vials of 5 mg, 10 mg,...

Volume pricing applied automatically at checkout, mixed compounds count

3+ vials −5% 5+ vials −10% 10+ vials −15%

For research use only
Lyophilised powder
Sealed glass vial
Ships from the EU · 1 to 3 working days
COA on request for documented batches

Intended use: Laboratory research only. Not for human or veterinary use.
Not a: Medicine, supplement, food or cosmetic
Advice: No dosing or medical advice is provided

Sealed vial: -20 °C for long-term storage, 2 to 8 °C for a few weeks, dry and dark
Reconstituted: Keep at 2 to 8 °C and use within a short period
Solvent: Bacteriostatic water, added slowly along the glass, never shaken

Documented batches: Products marked "COA on file" carry a certificate of analysis
Tests: Identity and purity per batch
Request: Send us the lot number on your vial and we send the report

3 or more vials: 5 % off every vial
5 or more vials: 10 % off every vial
10 or more vials: 15 % off every vial
Mixed orders: Different compounds count together, applied at checkout

Europe: 1 to 3 working days, tracked
Dispatch: Same or next working day from our EU warehouse
Packaging: Dry lyophilised powder, plain packaging
Rates: Shown at checkout for your country

Unopened vials: Statutory return period, seal intact
Opened or reconstituted: Cannot be returned for safety reasons

Tirzepatide €45.00 Add

Documented, in stock, shipped from the EU.

1–3 days delivery across Europe

Tirzepatide is a synthetic dual receptor agonist research peptide addressing the GLP-1 and GIP receptors. Dual incretin compounds are widely used in metabolic research on glucose handling and energy balance. Supplied as lyophilised powder in sealed vials of 5 mg, 10 mg, 15 mg or 30 mg. Certificate of analysis on file.

Specifications

Compound	Tirzepatide, dual incretin receptor agonist
CAS number	2023788-19-2
Molecular formula	C225H348N48O68
Molecular weight	approx. 4,814 Da
Receptors	GLP-1, GIP
Amount	5, 10, 15 or 30 mg per vial
Form	Lyophilised powder, sealed vial
Purity	Reported per batch (HPLC), see certificate of analysis
Documentation	Certificate of analysis on file

Research areas

Glucose metabolism studies
Energy balance models
Gut hormone signalling

Related compounds: Retatrutide (triple agonist) and Semaglutide (GLP-1 agonist).

Volume pricing: 3 or more vials save 5 %, 5 or more save 10 %, 10 or more save 15 %, applied automatically at checkout. Mixed compounds count together.

Storage and handling: keep the sealed vial at -20 °C for long-term storage, or at 2 to 8 °C for a few weeks, dry and away from light. Reconstitute with bacteriostatic water only when needed and keep the solution refrigerated. See our handling notes for details.

For laboratory research use only. Not for human or veterinary use, not a medicine, not a food or cosmetic. No dosing or medical advice is given.

Documented, not assumed

Every vial, documented.

How the compounds are tested, how to get the report, and how to handle the vial.

Per batch

Identity: Mass spectrometry
Purity: HPLC
Appearance: White lyophilised powder
Report: On request, by lot number

Questions about this product

The label states the amount of compound per vial in milligrams as filled. Purity for documented batches is reported in the certificate of analysis.

Bacteriostatic water for almost every compound in our range. It is available in 10 mL vials in the lab supplies category.

Much shorter than the powder. Keep it refrigerated at 2 to 8 °C and plan your research so that solutions are used within a short period.

Across Europe from our EU warehouse, delivery in 1 to 3 working days. Rates for your country are shown at checkout.

Unopened vials with intact seal can be returned within the statutory period. Opened or reconstituted products cannot be taken back.